KCCure joins 239 advocacy organizations asking Congress and CMS to reconsider changes allowing Medicare Advantage plans to implement a new policy that could negatively impact Medicare patients with kidney cancer.
This is to notify the research community of the recently extended deadline for the Fiscal Year 2018 (FY18) funding opportunities for the Department of Defense (DOD) Kidney Cancer Research Program (KCRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP).
On September 7th, the Harvard Medical Research Centers including Dana Farber, Beth Isreal, Brigham & Women's will once again hold their annual Kidney Cancer Symposium at the Newton Massachessetts Marriott. The Symposium is an all-day in-person and virtual event beginning at 8:00 a.m. and concluding at 3:30 pm.
Barbara Muchow is a kidney cancer survivor. She shares a beautiful story of friendship and loss and how it led to an early diagnosis of kidney cancer. To tell my cancer story I have to tell about my best friend of 40 years, Dorothy. Actually, Dorothy, her husband Bob and my husband and I were all best friends. We first met in Illinois as young parents and ended up in Nevada as retirees. Dorothy an...
KCCure tribute to Alison McDonough who bravely battle papillary RCC.
KCCure hits goal of raising $50,000 in new kidney cancer research funding. Learn more about our Kidney Cancer Research Grant Program and our mission for find a cure for kidney cancer.
KCCure tribute to Joe Paterniti (1969-2017) a dedicated father and husband who lost his life to kidney cancer.
July 30, 2018 Washington, DC, – The Kidney Cancer Research Alliance(KCCure) responded to the Committee for Medicinal Products for Human Use (CHMP) recommendation against approval by the European Medicines Agency (EMA) of ipilimumab (Yervoy) combined with nivolumab (Opdivo) for the first line treatment of high and intermediate risk metastatic renal cell carcinoma (kidney cancer). The question of si...
Katherine Battle was nine when her dad died of kidney cancer. In this essay she writes about loss, remembrance and above all things - enduring love. The past can't be changed - but her voice gives us all hope for the future.
"I realize that there is no avoiding death from this disease, so I plan for its eventuality but I refuse to stop living. Cancer does not define me." James is a stage 4 kidney cancer survivor and this is is his story.
Julie is a stage 4 kidney cancer survivor and author of the blog: Julie's Not Dying Today. Her latest post about working with Sonya Owens, a Licensed Clinical Social Worker on managing emotional aspects of cancer is something that all patients can benefit from. Thank you Julie for educating and inspiring!
When it comes to kidney cancer, a tie isn’t good enough. We need a win. Join our month-long fundraising effort, No Tie July, and help us raise one year of life-saving research funding in just one month.